158 results
8-K
EX-10.2
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
until a default occurs under such other security) than the rights and benefits established in favor of the Buyer by this Agreement or the Note unless … , in any such case, the Buyer has been provided with such rights and benefits pursuant to a definitive written agreement or agreements between
8-K
EX-10.3
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
) of the Code or qualification for the benefits of an income tax treaty to which the United States is a party, and any other form prescribed by applicable
8-K
EX-10.4
acihie
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.6
irdd9
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.3
fyx1s78w8 c4j78wym
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.2
wcjxcrr a2f6g358
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-99.1
f2et65jnvptg85aiyszn
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.1
brlxw9utqd
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.4
k3aq4o xk3si4m2ch
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
fqdiskqqp
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
hjglvqsp
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.4
kymowf d6koyevc
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-99.1
mu1ipiqn
28 Dec 23
Other Events
4:14pm
8-K
EX-99.1
rqvyg5
27 Dec 23
NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease
4:02pm